The aim of this study was to compare results obtained by eight different short-term assays of estrogenlike actions of chemicals conducted in 10 different laboratories in five countries. Twenty chemicals were selected to represent direct-acting estrogens, compounds with estrogenic metabolites, estrogenic antagonists, and a known cytotoxic agent. Also included in the test panel were 1 7,Bestradiol as a positive control and ethanol as solvent control. The test compounds were coded before distribution. Test methods included direct binding to the estrogen receptor (ER), proliferation of MCF-7 cells, transient reporter gene expression in MCF-7 cells, reporter gene expression in yeast strains stably transfected with the human ER and an estrogen-responsive reporter gene, and vitellogenin production in juvenile rainbow trout. 17p-Estradiol, 177a-ethynyl estradiol, and diethylstilbestrol induced a strong estrogenic response in all test systems. Colchicine caused cytotoxicity only. Bisphenol A induced an estrogenic response in all assays. The results obtained for the remaining test compounds-tamoxifen, ICI 182.780, testosterone, bisphenol A dimethacrylate, 4-n-octylphenol, 4-n-nonylphenol, nonylphenol dodecylethoxylate, butylbenzylphthalate, dibutylphthalate, methoxychlor, o,p'-DDT, p,p'-DDE, endosulfan, chlomequat chloride, and ethanol-varied among the assays. The results demonstrate that careful standardization is necessary to obtain a reasonable degree of reproducibility. Also, similar methods vary in their sensitivity to estrogenic compounds. Thus, short-term tests are useful for screening purposes, but the methods must be further validated by additional interlaboratory and interassay comparisons to document the reliability of the methods. -Environ Health Perspect 1 07(Suppl 1): 89-108 (1999). http://ehpnetl.niehs.nih.gov/docs/1999/Suppl-1/89-108andersen/ abstract.html
Several man-made chemicals that are and the toxicology of the substances are widely distributed in the environment may poorly understood. have the potential to mimic estrogens or Estrogenic chemicals identified to date otherwise disrupt the endocrine system include some organochlorine pesticides, (1) (2) (3) (4) . Reliable short-term methods are such as o,p'-DDT and methoxychlor, and needed to identify such chemicals, to char-industrial chemicals and byproducts, acterize and control the environmental including some polychlorinated biphenyl load, and to evaluate human exposures. congeners, alkyl phenols, phthalates, and Attempts to develop these methods must bisphenol A (5) (6) (7) (8) . The chemical structure confront the problem that the biologic fate of these chemicals varies substantially, which makes it difficult to predict their estrogenicity solely on a structural basis.
Estrogenicity was first defined as a physiologic response to a compound that induced estrus in vivo. An in vivo rodent uterine bioassay was developed in which an estrogen-induced uterotropic response was estimated as an increase in uterine tissue mass in ovariectomized or immature rodents (9) . This assay is often regarded as a gold standard. However, although it has been widely used for many years, the assay has still not been fully standardized (10) , and even when the same protocol is used, the results sometimes vary between different laboratories (11, 12) . Finally, different tissues may respond differently to estrogenic chemicals. A well-known example is tamoxifen, an antiestrogen in breast tissue but a uterotropic estrogenic agonist in uterine tissue (13) . More broadly based in vivo assays should aim at detecting the response in different tissues, thereby becoming more sensitive and informative.
The advantages of the rodent uterotropic assay and other in vivo assays are that they take into consideration the effects of metabolism, plasma-protein binding, and pharmacokinetics. These methods can also detect estrogenic responses due to altered metabolism of exogenous or endogenous estrogens as caused by, for example, some hepatotoxic chemicals such as carbon tetrachloride (14) . However, in vivo methods are in general expensive and time-consuming, and a variety of short-term assays are therefore being applied to identify estrogenic chemicals and to determine the relative potencies for hormonal responses. Some of these assays may be suitable for screening large numbers of chemicals and contaminated media, such as water and food, and may therefore be useful tools for prioritizing chemicals for more extensive studies in vivo.
However, most in vitro assays estimate primarily the intrinsic estrogenic activity of the chemicals as reflected by their binding to and activation of the estrogen receptor (ER) without taking into account factors that may affect their activity in the intact organism. These factors include: binding afflnity of the chemical to proteins (especially sex-hormone binding globulin [SHBG] and albumin), ability to enter target cells, degradation time in the organism, and the concentration of endogenous estrogen.
Most circulating endogenous estrogen (> 99%) is bound to plasma proteins and only a minor fraction is able to penetrate into the cells and activate the ER. Estrogenic chemicals such as o,p'-DDT, octylphenol (15) , bisphenol A (16) , and the potent synthetic estrogen diethylstilbestrol (DES) ( 15,1/) have a much lower affinity for these proteins than does 17p-estradiol.
Hence, the major part of these chemicals in the blood would be available for activation of the cellular ER. The relative potency of the chemicals compared to estradiol may therefore be underestimated by in vitro tests conducted without addition of plasma proteins, as has recendy been demonstrated for bisphenol A (16) .
The biodegradation of estrogenic chemicals may influence the estrogenic response, as a long degradation time could enhance the response. Some environmental chemicals are very lipophilic and resistant to metabolism and may therefore accumulate in organisms and reach concentrations sufficient to produce estrogenic responses in vivo. Hence, although the environmental estrogens characterized to date are considerably less potent than estradiol (1/50th to 1/10000th) based on ER binding affinities or effects seen in cell cultures (5, 18) , low concentrations may still be detrimental to the reproductive success of exposed organisms. For example, feminization and decreased reproduction in gulls was apparendy elicited by o,p'-DDT in eggs at concentrations as low as 5 mg/kg, which is similar to concentrations reported in the environment (19 (5) and by induction ofvitellogenin in male fish (20) .
To obtain a reliable screening system for estrogenicity, it is necessary to (7, (21) (22) (23) . In this study, 10 Finally, an in vivo assay using induction of vitellogenin in juvenile rainbow trout was included because vitellogenin induction in juvenile or male fish is reportedly a very sensitive biologic marker for estrogenicity (20) . Several of the assays (e.g., the E-SCREEN and the yeast assays) have been widely used in an attempt to identify estrogenic chemicals (5, 8, (24) (25) (26) (27) (28) .
The test chemicals ( Cells. The complete coding region of the ER (amino acids 2 to 595) was prepared by reverse transcriptase-polymerase chain reaction (RT-PCR) from cDNA prepared from total RNA from MCF-7 cells. cDNA was synthesized from 1-pg total RNA using 0.5-pg T14V primer (V corresponds to A, C, or G) as described in Ausubel et al. (44) . One microliter of the cDNA sample was used for PCR using 5 p native Pfu-enzyme (Stratagene, La Jolla, CA) including 30 pmol of each primer:
5'-primer: 5'-CGGGGA TCCACCAT GACCCTCCACACCAAAG-3';
3'-primer: 5'-GA GGAA TTCCGACT GTGGCAGGGAAACCCTC-3'. Nucleotides in italics were added to facilitate cloning. The cycle conditions on a GeneAmp PCR System 9600 (PerkinElmer Corp., Norwalk, CT) were 960C for 3 min, followed by 40 cycles of 96°C for 30 sec, 680C for 1 min, 740C for 3 min, and finally, 740C for 8 min. The ligand-binding domain (LBD) (amino acids 282 to 595) was prepared from the complete coding region DNA fragment by PCR as described previously, except that the 5'-primer was exchanged with 5'-GAAGGATCCTCT GCTGGAGACATGAG-3' and only 15 CD-treated human serum [laboratories 1 and 3] supplemented to phenol red-free DME). CD-treated FBS and CD-treated human serum were prepared as described by Soto et al. (48) based on plasma supplied from local blood banks. A range of concentrations of the test compounds was added to this medium. All chemicals were diluted to desired concentrations with DME immediately prior to use. The bioassay was terminated on day 6 (late exponential phase) by removing the media from the wells. In laboratory 2 a cell-lysing solution (10% ethylhexadecyl-dimethylammonium bromide) (Eastman Kodak, Rochester, NY) in 0.5% Triton X-100, 2 mM MgCl2, 12 mM NaCl, 5 mM phosphate buffer, pH 7.4) was added and the nuclei counted in a Model ZM Coulter Counter Apparatus (Coulter Electronics, Hialeah, FL). In laboratories 1 and 3 the cells were fixed and stained with sulforhodamine-B (SRB) as described by Brotons et al. (24) and Villalobos et al. (49) . Briefly, cells were treated with cold 10% trichloracetic acid (TCA) and incubated at 40C for 30 min, then washed five times with tap water and left to dry. TCAfixed cells were stained for 10 min with 0.4% (w/v) SRB dissolved in 1% acetic acid. Wells were rinsed with 1% acetic acid and air dried. Bound dye was solubilized with 10 mM Tris base (pH 10.5) in a shaker for 20 min. Finally, aliquots were transferred to a 96-well plate and read in a Titertek Multiscan plate reader (Titertek Instruments, Inc., Huntsville, AL) at 492 nm (laboratory 3). In all three laboratories the mean cell numbers from each experiment were normalized to the steroid-free control cultures to correct for differences in the initial seeding density. Data represent the mean and are pools of either one (laboratory 3), at least two (laboratory 1), or at least three (laboratory 2) independent experiments run in duplicate.
Transient Gene Expression Assay in Routledge and Sumpter (27) . The test chemicals were serially diluted in absolute ethanol and 10 pl of each concentration was transferred to a 96-well optically flat-bottom microtiter plate (Titertek) and allowed to evaporate to dryness on the assay plate. Aliquots (200 pl) of medium containing recombinant yeast and the chromogenic substrate chlorophenol red-P-D-galactopyranoside (Boehringer Mannheim, East Sussex, UK) were then dispensed to each sample well. Details of preparation of medium components are discussed in Routledge and Sumpter (27) phenyl-D-galactopyranoside (ONPG) (4 mg/ml in Z-buffer) was added and the reactions returned to 30°C for between 5 and 60 min. The reactions were terminated by the addition of 400 pl 1 M NaCO3, the cell debris was removed by centrifugation, and the absorbance at 420 nM measured (A420). The growth of the yeast strains was monitored by measuring the absorbance at 600 nM (A600). Miller units were determined using the following formula: [A420/(A600 of 1/10 dilution of cells x volume of culture x length of incubation)] x 1000. The data represent mean from three independent experiments with determinations in triplicates.
Recombinant Yeast Estrogen Screen Using Rainbow Trout Estrogen Receptor (Laboratory 5). Saccharomyces cerevisiae (strain BJ-ECZ) were stably transfected with the rainbow trout estrogen receptor (rtER) gene and an estrogen-responsive reporter gene containing two ERE linked to the yeast CYC1 promoter located upstream of the E.
coli gene for f-galactosidase (lacZ) as described by Petit et al. (53) . The cells were grown in liquid culture in the absence (negative control) or presence (positive control) of 10 nM 17p3-estradiol or test chemicals at 10 PM (1:1000 dilution of the stock solutions directly in the yeast culture media) for 4 hr at 28°C. Cells were harvested, lysed, the cell density was determined at 600 nm, and the f3-galactosidase activity was measured at 420 nm using ONPG as substrate. The data represent the mean from three replicates in a single experiment. Microtiter plates were coated with specific antibodies and blocked with BSA (3%). Vitellogenin standards or samples were added followed by incubation with horseradish peroxidase-coupled antibodies. The color development after adding enzyme substrate (OPD) was monitored at 490 and 650 nm. The resulting assay had a linear range of 5 to 50 ng/ml and a detection limit of 500 ng/ml serum. The concentration of vitellogenin in serum at day 0 and day 9 was measured in samples from each fish and the difference in vitellogenin calculated. In cases where the vitellogenin levels were below the detection limit of the assay, the concentration of the sample was set to the detection limit of 0.5 pg/ml. The pM, whereas the response at higher concentrations was decreased because of toxicity ( Figure 4) . Tamoxifen, but not ICI 182.780, induced vitellogenin production in rainbow trout. However, the level of vitellogenin produced was only 0.04% of the level induced by 17restradiol at 1% of the dose of tamoxifen (Figure 2 ). Although no ER binding was registered in the binding assays ( o,p'-DDT, p,p'-DDE, and chlormequat chloride, which at concentrations of 2.5, 10, and 2.5 pM, respectively, induced increases in CAT activity 2.5 to 3 times higher than the hormone-free control level ( Figure 5) The incubation time used in both laboratories was 72 hr for all test substances. However, incubation time has a pronounced effect on the level of P-galactosidase activity induced by several chemicals. In laboratory 6 the activity induced for all test chemicals was determined after both 72 and 93 hr. After 93 hr, P-galactosidase activities induced by 4-n-OP, 4-n-NP, bisphenol A dimethacrylate, and o,p'-DDT were considerably higher than after 72 hr (data not shown).
In the yeast strain DY150, a single concentration of 10 pM of each compound (10 nM for 17,-estradiol) was tested. Bisphenol A induced a weak estrogenic response after 18 hr incubation; the other environmental chemicals were inactive. The 0-galactosidase activity after addition of o,p'-DDT, p,p'-DDE, and endosulfan was even below control, thus possibly indicating a toxic response to the high concentrations used in this assay ( Figure 6 ).
Also in the yeast system expressing the rtER, only a single concentration of 10 (55) show that the ER exists as two different subtypes: ER-a and ER-p.
Differences in relative ligand binding affinity and tissue distribution of the two ER subtypes could possibly explain some of the discrepancies in binding affinities observed in the two binding assays. Another possible explanation is that the recombinant hER binding assay is based on isolated ER without any other cellular constituents, whereas the LBA based on rabbit uterus includes cytosol-containing cellular proteins with possible metabolizing capacity. The existence of metabolizing enzymes is supported by the ability of methoxychlor to inhibit the binding of 3H-17p-estradiol to the ER in this assay because only the demethylated metabolite, not methoxychlor itself, binds to the ER (40, 56) .
The E-SCREEN assay was performed in three different laboratories. In one laboratory the MCF-7 cell proliferation was determined by direct cell counting; a staining technique was used in the other two laboratories. For several of the test compounds, good agreement was observed among the results obtained in the three laboratories. However, tamoxifen, testosterone, BBP, o,p'-DDT, p,p'-DDE, and chlormequat chloride showed discrepant responses in the three laboratories ( Figure  3 ). ER expression in MCF-7 cells is modified by factors such as growth rate and cell density (57) , and different MCF-7 stocks may exhibit different responses to estradiol and chemicals with estrogenic activity (49) . However, cells from the same MCF-7 stock (BUS) were used in all three laboratories. Binding proteins (SHBG and albumin) seem to be present in charcoalstripped serum and approximately 85% of estradiol is bound to plasma proteins in the E-SCREEN assay when 10% CDtreated serum was added to the medium (58) . In this study CD-treated serum was prepared in the individual laboratories, and minor differences in protein content cannot be excluded. In two of the laboratories, 10% CD-treated serum-and in one laboratory 5% CD-treated serumwas added to the test medium. Because the proliferation was induced to similar degrees by 17p-estradiol in the three laboratories, this difference in procedure apparently does not affect the results.
It has been discussed whether cell proliferation or activation of reporter genes is the most reliable end point to estimate estrogenic potency (5) . In this study, the proliferation assay (E-SCREEN) and the reporter gene expression assay in MCF-7 cells showed good agreement regarding chemicals identified as estrogenic or nonestrogenic, although the dassification as fiull, partial, or weak estrogens varied somewhat between the assays (Figures 3 and 5) . In the reporter gene expression assay, the test compounds were examined at only one concentration after ensuring that it was the highest nontoxic concentration to the cells. Hence, the response obtained will probably be dose to the maximal estrogenic response of the test chemical in this assay. The responses calculated as percentages of the response induced by 170-estradiol were in general lower in the reporter gene expression assay than in the proliferation assay; therefore most chemicals identified as full or partial estrogenic agonists in the proliferation assay were judged as partial or weak agonists, respectively, in the reporter gene assay. Only one of the environmental chemicals (bisphenol A) induced a full estrogenic response in both assays. Endosulfan induced no reporter gene activation above the hormone-free control at 25 pM but a weak proliferation response at 5 to 10 pM. Differences in sensitivity to estrogens between different MCF-7 cell stocks (49) may contribute to deviations in the response pattern between the two assay systems because different stocks of MCF-7 cells were used.
The assay based on hER expression in Saccharomyces was used in two different laboratories. Their results were similar, although one laboratory consistently tended to obtain slightly higher results than the other laboratory (Figure 4) . However, for most of the chemicals the two laboratories agreed on classification as strong, partial, or weak estrogens, or as nonestrogenic. The yeast assay is not always capable of discriminating between antagonists and agonists, as the pure antiestrogen ICI 182.780 and the partial antiestrogen tamoxifen both induced increased P-galactosidase activity. This finding is in agreement with earlier observations (59) and thus indicates that both tamoxifen and ICI 182.780 bound to ER are able to induce expression of an ERE-linked reporter gene in yeast. The nature of agonist-receptor versus antagonist-receptor interaction and the resulting altered transcriptional activity are poorly understood. Metzger et al. (60) The stimulation of proliferation and transcriptional activity in MCF-7 cells by testosterone is in agreement with earlier findings and is thought to be due to conversion of testosterone to estradiol catalyzed by a high activity of aromatase present in these cells (61, 62) . In the different yeast strains, testosterone induced no response or a very weak response-a finding that is in accordance with earlier observations (15, 27) and the notion that yeast has no aromatase activity.
Among the environmental chemicals tested, bisphenol A induced the highest estrogenic response in all the assays, albeit the relative binding affinity for ER and the relative potency in the E-SCREEN and in the Saccharomyces hER assays were all a factor of 10,000 to 100,000 less than 173-estradiol (Table 4) . These results are in accordance with earlier reports on the binding affinity of bisphenol A for the ER (16, 26) and the induced proliferation in MCF-7 cells (26) . Low doses of this chemical may induce biologic responses in vivo. When bisphenol A was fed to pregnant mice, doses of only 2 and 20 ,ug/kg/day significantly increased the adult prostate weight of the males exposed in utero (16) . In the present study a single dose of 50 mg/kg induced a marked increase in vitellogenin production in rainbow trout (Figure 2 Although most of the alkylphenols used in different products are branched, this study included the well-defined unbranched alkylphenols 4-n-OP and 4-n-NP. Binding affinities to recombinant hER for 4-n-OP and 4-n-NP in this study were relatively high, with IC50 values of 4.0 and 4.3 FM, respectively, corresponding to binding affinities of approximately 1/3000th that of 17P-estradiol (Table 3) . These affinities did not differ much from binding affinities to ER isolated from rainbow trout liver for mixed isomers of 4-tert-OP and 4-NP (31). 4-NP may be released from certain types of plastic centrifuge tubes and then induce cell proliferation and increases in progesterone receptors in MCF-7 cells, and it triggers mitotic activity in rat endometrium (33) . In this study both 4-n-OP and 4-n-NP induced cell proliferation and transcriptional activation in MCF-7 cells, albeit to a different level than that of 17p-estradiol (Figures 3 and 5 ). 4-n-OP was the most potent of the two alkylphenols, which is in accordance with findings of most previous studies (18, 31) . However, a recent study reported that 4-NP had higher estrogenic potency than 4-OP (23) . Maximal response in the proliferation assay was seen at concentrations of 10 pM, and toxic effects occurred at higher concentrations. Both chemicals were also toxic to the yeast strain expressing the hER (Figure 4 ). 4-n-OP killed the yeast in both laboratories using this assay and only a weak estrogenic response was induced at low doses not associated with cytotoxicity. 4-n-NP induced a partial agonistic response in one laboratory but killed the yeast in the other laboratory. In a previous study using the same assay conditions, both 4-tert-OP and 4-NP stimulated 0-galactosidase activity to a similar extent as 17p-estradiol but with potencies of 1/1000th and 1/30,000th that of 170-estradiol (35) . In another yeast assay using the strain BJ2407 containing the hER, overnight incubation with 10 pM 4-OP significantly increased j-galactosidase activity to a similar extent as 17J8-estradiol although the potency was 1000-fold less than 17rvestradiol (15) .
In the assay using Saccharomyces containing the rtER, a strong response was induced by both alkylphenols at 10 pM (Figure 7) . Differences in the primary structure of especially the N-terminal domain of rtER and hER and differences in binding affinity for 17i-estradiol between the two ER receptors have been reported (53) . Thus, the discrepancy in the results between yeast containing the hER and yeast containing the rtER might be due to differences in transactivation of I-galactosidase activity caused by differences in binding affinities between the two receptors and the alkylphenols tested. Another possible explanation is that the shorter incubation time used in the rtER yeast assay (4 hr) than in the hER yeast assay (72 hr) may preclude a toxic effect.
Although both alkylphenols activated the rtER in the yeast assay, neither 4-n-OP nor 4-n-NP induced increased vitellogenin synthesis in juvenile rainbow trout at the doses investigated in this study (Figure 2) . NP induces vitellogenin production in rainbow trout after exposure to only 10 ppb NP in a flow-through system for 72 hr (32) . In addition, 4-NP and 4-tert-OP both induced synthesis of vitellogenin in rainbow trout hepatocytes in vitro (63) . In rodents, low doses of NP (10 pg/day for 1 1 days) increased proliferation of the mammary epithelial cell of female rats by 200% compared to that of controls (34) .
The apparent discrepancy between some of the results obtained for the two alkylphenols is probably due to the use of either unbranched or technical grade isomer mixtures, and interpretation is hampered by the lack of detail on the isomer characteristics of the alkylphenols used. The estrogenic potency of alkylphenols is likely to depend on both the position and branching of the alkyl group (35). 4-Tertiary branched alkyl groups of six to eight carbons located at the para position were most estrogenic and approximately 30-fold more potent than 4 normal and 4 secondary equivalents when evaluated in a yeast assay (35) . In another yeast assay technical grade NP was approximately twice as potent as straight-chain n-NP in inducing 3-galactosidase activity after 18 hr of incubation (23) . In the rodent uterotropic assay technical NP, but not n-NP, induced a dose-related positive response (12) .
With regard to the phthalates, both BBP and DBP bind to the ER from rainbow trout liver and induce proliferation and reporter gene activation in MCF-7 cells (6) and in yeast (28) . BBP (28) . In the present study BBP bound to the recombinant hER (but not rabbit uterus ER) (Table 3) and induced full or partial estrogenic responses in the E-SCREEN (Figure 3 ) and weak estrogenic responses in the reporter gene assays in MCF-7 cells ( Figure  5 ), yeast (Figures 4,7) , and in the in vivo vitellogenin assay. The potency of BBP in the E-SCREEN was estimated to be 1/ 10,000,000 to 1/1,000,000 that of 1U7P-estradiol. DBP was inactive in most of the assays, except the two MCF-7 cell assays in which a weak or partial est-rogenic response was induced. Hence, the results obtained are in good agreement with previous findings that BBP and DBP are weakly estrogenic compounds, with BBP being the most potent.
Several organochlorine pesticides induce estrogenic responses in vivo (64) and in vitro (25, 65) . In agreement with other studies (21), a strong binding affinity of o,p'-DDT was found for recombinant hER, and a strong estrogenic response was demonstrated in MCF-7 cells either by increased proliferation or induction of transcriptional activity. The relatively low estrogenic response induced in yeast expressing the hER was similar to previously reported results when the same yeast strain and assay conditions were used (27) and may be caused by reduced availability of o,p'-DDT due to adherence to the surface of the assay plate. Thus, a higher and steeper response curve was induced if o,p'-DDT was added directly to the medium (Figure 8 ). In a study using another yeast strain (BJ2407) and direct addition of o,p'-DDT to the medium, a full estrogenic response to 1 and 10 pM o,p'-DDT was observed (21) . The major DDT metabolite p,p'-DDE had a lower binding affinity for the ER and showed less estrogenicity in MCF-7 cells than o,p'-DDT-in agreement with earlier reports (43) . In yeast, p,p'-DDE was unable to induce ,B-galactosidase activity at the concentrations tested. Besides the weak estrogenicity of p,p'-DDE, this compound is an androgen receptor antagonist (43) .
In agreement with other studies, methoxychlor induced an estrogenic response in MCF-7 cells (5 progesterone receptors (5) .The binding affinity of endosulfan for ER was approximately 1/10,000th that of 17,B-estradiol (5), which was also found for recombinant hER in this study (Table 3) . A weak increase in 3-galactosidase activity induced by endosulfan has been reported in the yeast strain BJ2407 expressing the hER (66) . In the present study endosulfan induced only a weak proliferative response in MCF-7 cells (Figure 3 ) and in yeast expressing the rtER (Figure 7 ) and no estrogenic response in the transactivation assay in MCF-7 cells ( Figure 5 ) or in the yeast assays containing the hER (Figure 4) . None of the pesticides-o,p'-DDT, p,p'-DDE, methoxychlor, or endosulfaninduced increased vitellogenin production in rainbow trout in this study (Figure 2 Therefore, the results obtained should not be disregarded because of the possibility of contamination. The overall findings are in good agreement with those of previous studies, and some chemicals induced responses lower than the ethanol. Further, for each test substance aliquots from the same stock solution were transferred to the test vials so that all participating laboratories (except for the vitellogenin assay in laboratory 9) tested exactly the same solutions. The inclusion of a solvent control prepared together with strongly estrogenic chemicals shows that laboratory contamination can occur despite rigorous hygiene procedures. Indeed, that possibility was considered when the study was designed. This experience therefore emphasizes that results identifying a new estrogenic compound should be reproducible in more than one laboratory, as there will always be a risk of contamination with potent estrogens present in the laboratory. In addition, it shows the importance of meticulous procedures for handling potent estrogens. Inclusion of solvent controls prepared before, concurrently, and after preparation of the test substances is recommended to document that no cross-contamination has occurred. Pretesting solvent controls in at least one sensitive assay system before distribution to the other participating laboratories could also be considered.
Finally, the data also allow a preliminary assessment of the validity of the tests used, based on the results obtained with similar methods used in different laboratories and with different methods based on related principles. The advantages and disadvantages must be carefully considered, in particular when choosing one or more tests for screening purposes.
The only a single relatively high concentration (10 pM) of each test substance was used. In the former assay only a few chemicals showed a positive response after an 18-hr incubation. In several cases the response was less than the response in untreated controls, thus indicating a toxic response. This observation illustrates the importance of using several concentrations of the test substances or ensuring that the concentrations used are nontoxic to the assay system to avoid false negatives due to estrogenic responses hidden by toxicity. In the Saccharomyces assay with the rtER, toxicity may have been minimized by a shorter incubation time of 4 hr. Hence, the influence on the results of the specific assay conditions as well as the specific yeast strain, the origin of the ER, and the reporter gene construct must be further documented. Because the application method of the test compounds and the incubation time influenced the results, the assays must be optimized to obtain reliable results. When standardized assay conditions are used in different laboratories, the results obtained with the Saccharomyces expressing the hER appear reproducible.
The vitellogenin assay in rainbow trout is more cumbersome and expensive but has the advantage of being a short-term in vivo system. This method is less suitable for preliminary screening but may be useful for retesting chemicals that are positive in one of the preliminary assays. However, the exact procedure for the vitellogenin assay should be further evaluated regarding exposure time and dose level to avoid false negative results.
The specificity of the methods cannot be determined in this study because the true estrogenic response is unknown for several of the test compounds. However, as a first rapid screening assay for estrogenicity of chemicals, at least two assays should probably be carried out with a view to high sensitivity, standardized conditions, and ease in performance. Realistic candidates are the recombinant hER LBA and the E-SCREEN, as these assays have high sensitivity, are easy to perform, and in combination provide information on both receptor binding and a cellular response.
In the future development of short-term tests, additional comparisons will be necessary, standardization will be obligatory, and, quite likely, no single test will be found valid either for exclusion or for verification of estrogenicity. Better information on the metabolic capacity of the test systems is needed, and addition of metabolic enzymes to the in vitro assays may improve their reliability and comparability. Also, the subtype of ER in the individual assays must be taken into account. Although important differences between the tests have been documented in this study, the results suggest that it will be feasible to design a battery of tests for screening of estrogenicity of environmental chemicals.
